Galera Therapeutics Inc Stock News
$0.02
0.00%
day before yesterday
Nasdaq,
Nov 28, 04:07 pm CET
Galera Therapeutics Inc Stock News
Neutral
GlobeNewsWire
●
about one month ago
Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera's dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The agreement includes 1) an upfront payment of $3.5 million, 2) potential future regulatory milestones, commercial milestones, and contingent value rights of up to $105 million.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
